VCYT
Veracyte Inc

1,254
Mkt Cap
$3.29B
Volume
749,669.00
52W High
$50.71
52W Low
$22.61
PE Ratio
109.48
VCYT Fundamentals
Price
$41.57
Prev Close
$41.00
Open
$41.15
50D MA
$43.30
Beta
1.62
Avg. Volume
769,078.82
EPS (Annual)
$0.3088
P/B
2.61
Rev/Employee
$540,975.73
Loading...
Loading...
News
all
press releases
Elekta Wins FDA Nod for Evo CT-Linac, Boosting U.S. Radiation Oncology
EKTAY jumps after FDA clears Evo CT-Linac, opening U.S. access to AI-driven CT imaging that boosts precision and efficiency in radiation therapy.
Zacks·15h ago
News Placeholder
More News
News Placeholder
Will Robust Adult Nutrition Business Performance Fuel ABT's Q4 Earnings?
ABT heads into Q4 earnings with adult nutrition in focus, as Ensure and Glucerna launches are expected to support modest segment growth.
Zacks·20h ago
News Placeholder
State of Alaska Department of Revenue Takes $1.50 Million Position in Veracyte, Inc. $VCYT
State of Alaska Department of Revenue bought a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·3d ago
News Placeholder
Sumitomo Mitsui Trust Group Inc. Sells 165,094 Shares of Veracyte, Inc. $VCYT
Sumitomo Mitsui Trust Group Inc. cut its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 10.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·4d ago
News Placeholder
SG Americas Securities LLC Increases Stock Position in Veracyte, Inc. $VCYT
SG Americas Securities LLC raised its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 124.4% during the third quarter, according to the company in its most recent 13F filing with the...
MarketBeat·4d ago
News Placeholder
Veracyte (NASDAQ:VCYT) Cut to Hold at Zacks Research
Zacks Research cut shares of Veracyte from a "strong-buy" rating to a "hold" rating in a research note on Tuesday...
MarketBeat·5d ago
News Placeholder
NTRA & NVDA Partner to Improve AI Models for Precision Medicine
Natera teams up with NVIDIA to train multimodal AI models, aiming to improve precision care through faster, scalable analysis of complex medical data.
Zacks·7d ago
News Placeholder
RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models
Revvity teams up with Eli Lilly to bring TuneLab AI models to Signals Xynthetica, aiming to unlock secure, federated drug discovery at scale.
Zacks·8d ago
News Placeholder
Summit Creek Advisors LLC Makes New $8.52 Million Investment in Veracyte, Inc. $VCYT
Summit Creek Advisors LLC bought a new stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and...
MarketBeat·8d ago
News Placeholder
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Zacks·12d ago
<
1
2
...
>

Latest VCYT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.